Short Interest Don’t Lie: Is Buying Vascular Solutions Incorporated (NASDAQ:VASC), Having Higher Short Interest a Winning Strategy?

November 18, 2016 - By Vivian Park   ·   0 Comments

Short Interest Don't Lie: Is Buying Vascular Solutions Incorporated (NASDAQ:VASC), Having Higher Short Interest a Winning Strategy?

The stock of Vascular Solutions Incorporated (NASDAQ:VASC) registered an increase of 1.7% in short interest. VASC’s total short interest was 1.06M shares in November as published by FINRA. Its up 1.7% from 1.04 million shares, reported previously. With 96,400 shares average volume, it will take short sellers 11 days to cover their VASC’s short positions. The short interest to Vascular Solutions Incorporated’s float is 6.7%. About 36,847 shares traded hands. Vascular Solutions, Inc. (NASDAQ:VASC) has risen 37.58% since April 18, 2016 and is uptrending. It has outperformed by 33.15% the S&P500.

Vascular Solutions, Inc. is a medical device firm focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The company has a market cap of $993.92 million. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. It has a 77.24 P/E ratio. The Company’s products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat.

Insitutional Activity: The institutional sentiment increased to 1.2 in Q2 2016. Its up 0.01, from 1.19 in 2016Q1. The ratio increased, as 10 funds sold all Vascular Solutions, Inc. shares owned while 44 reduced positions. 15 funds bought stakes while 49 increased positions. They now own 14.00 million shares or 4.98% more from 13.33 million shares in 2016Q1.
Thrivent Fincl For Lutherans has invested 0% of its portfolio in Vascular Solutions, Inc. (NASDAQ:VASC). Royal Bank Of Canada holds 732,653 shares or 0.02% of its portfolio. Moreover, Louisiana State Employees Retirement Systems has 0.02% invested in Vascular Solutions, Inc. (NASDAQ:VASC) for 7,700 shares. Blackrock Invest Mngmt Lc owns 74,611 shares or 0% of their US portfolio. Schwab Charles Invest holds 0% of its portfolio in Vascular Solutions, Inc. (NASDAQ:VASC) for 59,446 shares. Eqis Capital Management owns 7,026 shares or 0.02% of their US portfolio. The Switzerland-based Swiss Fincl Bank has invested 0% in Vascular Solutions, Inc. (NASDAQ:VASC). First Mercantile Trust has invested 0.01% of its portfolio in Vascular Solutions, Inc. (NASDAQ:VASC). Moreover, Henderson Public Ltd has 0.02% invested in Vascular Solutions, Inc. (NASDAQ:VASC) for 58,499 shares. Argent Capital Limited Liability owns 109,560 shares or 0.2% of their US portfolio. Cadence Management Limited Liability Com has invested 0.07% of its portfolio in Vascular Solutions, Inc. (NASDAQ:VASC). Neuberger Berman Gru Limited Company holds 830,550 shares or 0.05% of its portfolio. Wedge Mngmt L L P Nc holds 0.01% or 15,990 shares in its portfolio. Rhumbline Advisers, a Massachusetts-based fund reported 21,969 shares. Moreover, Pinebridge L P has 0% invested in Vascular Solutions, Inc. (NASDAQ:VASC) for 2,202 shares.

Insider Transactions: Since May 24, 2016, the stock had 0 insider buys, and 3 insider sales for $3.61 million net activity. 34,418 shares with value of $1.34 million were sold by ROOT HOWARD on Tuesday, May 24. 10,011 shares were sold by RUTSTEIN WILLIAM, worth $463,109.

Vascular Solutions, Inc. (NASDAQ:VASC) Ratings Coverage

Out of 3 analysts covering Vascular Solutions (NASDAQ:VASC), 3 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Vascular Solutions has been the topic of 3 analyst reports since July 22, 2015 according to StockzIntelligence Inc. The rating was initiated by Needham with “Buy” on Thursday, October 6. The stock of Vascular Solutions, Inc. (NASDAQ:VASC) earned “Overweight” rating by Piper Jaffray on Tuesday, August 11.

VASC Company Profile

Vascular Solutions, Inc., incorporated on December 20, 1996, is a medical device firm focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. The Company’s products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Firm creates minimally invasive medical devices and then delivers these products and related services to physicians through its direct domestic sales force and its international distribution network.

Another recent and important Vascular Solutions, Inc. (NASDAQ:VASC) news was published by Startribune.com which published an article titled: “Vascular Solutions, CEO acquitted of federal charges in off-label case” on February 26, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Vivian Park


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>